The Urinary Tract Infection (UTI) market is a subset of the Urology and Nephrology market. UTIs are caused by bacteria entering the urinary tract, and can cause pain, burning, and frequent urination. Treatment typically involves antibiotics, and in some cases, hospitalization. The market is driven by the increasing prevalence of UTIs, as well as the aging population and the rise of antibiotic-resistant bacteria. The market is composed of a variety of products, including antibiotics, urinary catheters, and other medical devices. Additionally, there are a number of services, such as diagnostic tests, hospitalization, and outpatient care. Some companies in the UTI market include Astellas Pharma, Pfizer, Merck, and Allergan. Other companies include C.R. Bard, B. Braun, and Cook Medical. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
